Tag: Healthcare

(Reuters) – The U.S. Centers for Medicare & Medicaid Services (CMS) on Friday proposed coverage of expensive CAR-T cell therapies at cancer centers that meet criteria including a registry or clinical study to monitor how well patients fare for at least two years after treatment. New hospital payment terms from Medicare, the federal government healthcare […]

Read more

FRANKFURT (Reuters) – Bayer is banking on the mild side effects of its experimental prostate cancer drug darolutamide, as it prepares to take on established rival products by Pfizer and Johnson & Johnson. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. […]

Read more

(Reuters health) – More young men and women are binge-drinking into their mid- and late-20s today than a generation ago, increasing their risk of accidental injuries, deaths and a variety of chronic illnesses, researchers say. Historically, binge drinking among both men and women has tended to increase from age 18 through the early 20s then […]

Read more

SYDNEY (Reuters) – An elderly man suffering Parkinson’s Disease and dementia was given 10 times his medication and had unexplained bruising when he died at an Australian aged care facility, his widow told an inquiry into the A$20 billion ($14 billion) aged care sector. A Royal Commission inquiry into Australia’s aged care industry began hearings […]

Read more

NEW YORK (Reuters) – Drugmakers Pfizer Inc, Bristol-Myers Squibb Co and Sanofi SA said on Wednesday that their chief executives plan to testify at a Senate hearing on rising prescription drug prices later this month. FILE PHOTO: Sanofi’s Chief Executive Officer Olivier Brandicourt attends the company’s shareholders meeting in Paris, France, May 2, 2018. REUTERS/Charles […]

Read more

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo CHICAGO (Reuters) – Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald […]

Read more

(Reuters health) – Kids living with type 1 diabetes are no different from their peers in their reading and math test scores, a Danish study suggests. The less common form of diabetes, known as type 1, develops in childhood or young adulthood when the pancreas fails to produce the hormone insulin, which is needed for […]

Read more

NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by Unitedhealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters. FILE PHOTO: The logo of Lilly is seen […]

Read more

NEW YORK/WASHINGTON (Reuters) – The U.S. government on Thursday proposed a rule to end the industry-wide system of after-market discounts called rebates that pharmacy benefit managers (PBMs) receive from drugmakers, a practice that has been under increased scrutiny. <img title="U.S. government proposes rule overhauling drug industry rebate system " alt="U.S. government proposes rule overhauling drug […]

Read more

NHS trusts could “quickly run out of vital medicine” in the event of a no-deal Brexit, the chief executive of a leading hospital group has warned. Dr David Rosser of University Hospitals Birmingham (UHB) said that, despite NHS stockpiling, shortages would likely occur due to “unprecedented” distribution challenges. medicine shortages could lead to some operations […]

Read more